Good morning, convener, and thank you. Pernicious anaemia can have a significant impact on the lives of those with the condition. People can be unwell for some time, having experienced difficulties in obtaining diagnosis and appropriate treatment. That is why I commend Mrs MacArthur for her determination and work to support all those who are living with the condition in Scotland.
I recognise that the committee might ask questions of a more clinical nature. That is why I am accompanied by Dr Padmini Mishra, one of the senior medical advisers in the CMO’s office, and Liz Sadler, who is the deputy director of planning and quality.
The petition was lodged in 2011, and I understand that at that time Mrs MacArthur hoped that the guidelines that were then available for general practitioners would be overhauled and updated. That was achieved by the publication in 2014 of the British Committee for Standards in Haematology guidelines.
The petition made several requests, and I will outline how they have been met. First, on the request for greater awareness of common sets of symptoms experienced by people suffering from a deficiency in vitamin B12, the GP training curriculum includes investigation related to all types of anaemia, including pernicious anaemia, and GPs are expected to be able to address the signs and symptoms of a patient presenting with pernicious anaemia. The British Society for Haematology guidelines further support healthcare professionals in the assessment and diagnosis of pernicious anaemia.
The second request was for an overhaul of the diagnostic tests that are used and to adopt the active B12 test, and for homocysteine and methylmalonic acid tests to be used regularly. I understand that there is no definitive test for diagnosing vitamin B12 deficiency, which is an area for experts in haematology that is addressed in the guidelines. The committee will understand that it is not appropriate for Scottish ministers or their policy officials to intervene in or contradict the evidence-based guidance that is produced by specialists in the field.
The next request was for patients displaying advanced symptoms to be automatically offered trial injections of vitamin B12. Again, the BSH guidelines state that that could be considered. The petitioner also asked that folate and ferritin be checked for, along with other coexisting conditions. The BSH guidelines also provide advice on folate deficiency, coexisting conditions and the provision of folic acid.
Lastly, the petitioner asked for patients to be able to self-inject vitamin B12 as and when they need it. All matters of treatment are for discussion and agreement between the individual and clinician concerned, and that is not and cannot be a matter for Scottish ministers to become involved in. However, I have been advised that self-administration can be challenging as it requires an intramuscular injection that has risks associated with it. As a result, some patients might not wish to self-inject, so that would have to be a matter for discussion between the individual and a clinician.
The BSH guidelines address the majority of the issues that were raised in the petition. However, at the time of their publication, Scottish Government advisers felt that the guidelines were not in a suitable format for use in GP practices—that is, they were not in a format that GPs were familiar with, such as the Scottish intercollegiate guidelines network or National Institute for Health and Care Excellence guidelines. As a result, the Scottish Haematology Society was asked to prepare a draft summary document of the guidelines. An initial draft was prepared but the SHS advised the committee that, because of the level of work required to complete the document, it had taken the decision to withdraw from the process, leaving the document in draft.
Committee members will be well aware that it is not the Scottish Government’s role to publish clinical guidelines or summary documents derived from them. However, I make clear that the content of the BSH’s guidelines was considered relevant and appropriate for adoption by Scottish clinicians, and that view is extant.
In 2015, the National Institute for Health and Care Excellence produced a clinical knowledge summary “Anaemia—B12 and folate deficiency”. Clinical knowledge summaries are designed to be concise, accessible summaries of current evidence for primary care professionals and are in a format that GPs are familiar with.
Our position is that the petitioner’s requests have been met. The chief scientist office within the Scottish Government, which has responsibility for the funding of clinical research in Scotland, would welcome applications for research projects aimed at the diagnosis and treatment of people with pernicious anaemia. The petitioner may want to consider that route, aided by the Pernicious Anaemia Society to identify researchers willing to move that forward.
I hope that my statement has addressed the substantive points in the petition and illustrated the progress that has been made. I am happy to take questions from the committee.